Shanghai Rightongene (China) Performance
| 688217 Stock | 20.84 0.26 1.23% |
On a scale of 0 to 100, Shanghai Rightongene holds a performance score of 11. The entity has a beta of -0.96, which indicates possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Shanghai Rightongene are expected to decrease slowly. On the other hand, during market turmoil, Shanghai Rightongene is expected to outperform it slightly. Please check Shanghai Rightongene's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Shanghai Rightongene's existing price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rightongene Biotechnology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rightongene sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0086 | Payout Ratio 9 | Forward Dividend Rate 0.18 | Ex Dividend Date 2023-11-30 |
1 | How AstraZenecas China fraud was about more than greed - ThinkChina | 11/07/2024 |
| Begin Period Cash Flow | 203.2 M |
Shanghai |
Shanghai Rightongene Relative Risk vs. Return Landscape
If you would invest 1,482 in Shanghai Rightongene Biotechnology on August 25, 2024 and sell it today you would earn a total of 602.00 from holding Shanghai Rightongene Biotechnology or generate 40.62% return on investment over 90 days. Shanghai Rightongene Biotechnology is generating 0.6854% of daily returns and assumes 4.7008% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Shanghai, and 87% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Shanghai Rightongene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Rightongene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shanghai Rightongene Biotechnology, and traders can use it to determine the average amount a Shanghai Rightongene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1458
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688217 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.7 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Shanghai Rightongene is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shanghai Rightongene by adding it to a well-diversified portfolio.
Shanghai Rightongene Fundamentals Growth
Shanghai Stock prices reflect investors' perceptions of the future prospects and financial health of Shanghai Rightongene, and Shanghai Rightongene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shanghai Stock performance.
| Return On Equity | -0.0148 | ||||
| Return On Asset | -0.0097 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 964.1 M | ||||
| Shares Outstanding | 55.86 M | ||||
| Price To Book | 1.25 X | ||||
| Price To Sales | 4.67 X | ||||
| Revenue | 258.21 M | ||||
| Gross Profit | 257.7 M | ||||
| EBITDA | 25.94 M | ||||
| Net Income | 7.93 M | ||||
| Total Debt | 5.82 M | ||||
| Book Value Per Share | 14.70 X | ||||
| Cash Flow From Operations | 45.1 M | ||||
| Earnings Per Share | (0.10) X | ||||
| Total Asset | 1.04 B | ||||
| Retained Earnings | 154.03 M | ||||
About Shanghai Rightongene Performance
By analyzing Shanghai Rightongene's fundamental ratios, stakeholders can gain valuable insights into Shanghai Rightongene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shanghai Rightongene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shanghai Rightongene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shanghai Rightongene is entity of China. It is traded as Stock on SHG exchange.Things to note about Shanghai Rightongene performance evaluation
Checking the ongoing alerts about Shanghai Rightongene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shanghai Rightongene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shanghai Rightongene appears to be risky and price may revert if volatility continues | |
| Shanghai Rightongene has high likelihood to experience some financial distress in the next 2 years | |
| About 41.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: How AstraZenecas China fraud was about more than greed - ThinkChina |
- Analyzing Shanghai Rightongene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shanghai Rightongene's stock is overvalued or undervalued compared to its peers.
- Examining Shanghai Rightongene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shanghai Rightongene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shanghai Rightongene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shanghai Rightongene's stock. These opinions can provide insight into Shanghai Rightongene's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shanghai Stock analysis
When running Shanghai Rightongene's price analysis, check to measure Shanghai Rightongene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rightongene is operating at the current time. Most of Shanghai Rightongene's value examination focuses on studying past and present price action to predict the probability of Shanghai Rightongene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rightongene's price. Additionally, you may evaluate how the addition of Shanghai Rightongene to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |